Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
03:10:13 EST Sun 08 Feb 2026
Enter Symbol
or Name
USA
CA



Q:INSM - INSMED INC - https://www.insmed.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
INSM - Q2.5147.90·150.650.3149.86-1.17-0.82,629.5395,68030,199153.06  155.79  149.34212.75  60.4019:59:10Feb 0515 min RT 2¢

Recent Trades - Last 10 of 30199
Time ETExPriceChangeVolume
19:59:10Q150.65-0.385
19:54:39Q149.02-2.0130
19:40:01Q149.11-1.921
18:30:40Q149.33-1.704
18:27:12Q148.00-3.031
18:15:13Q149.33-1.707
18:13:41Q148.81-2.225
18:13:41Q149.01-2.021
18:13:41Q149.01-2.021
18:13:15Q148.9689-2.061112

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-02-05 07:00U:INSMNews ReleaseInsmed to Host Fourth-Quarter and Full-Year 2025 Financial Results Conference Call on Thursday, February 19, 2026
2026-01-28 07:00U:INSMNews ReleaseInsmed to Present Multiple Abstracts on Treprostinil Palmitil Inhalation Powder (TPIP) at Pulmonary Vascular Research Institute (PVRI) 2026 Congress
2026-01-09 07:00U:INSMNews ReleaseInsmed Provides Business Update at 44th Annual J.P. Morgan Healthcare Conference
2026-01-02 07:00U:INSMNews ReleaseInsmed To Present at the 44th Annual J.P. Morgan Healthcare Conference
2025-12-17 16:01U:INSMNews ReleaseInsmed Provides Clinical and Business Update
2025-12-04 07:00U:INSMNews ReleaseInsmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
2025-11-18 11:00U:INSMNews ReleaseEuropean Commission Approves BRINSUPRI(TM) (brensocatib) as the First and Only Treatment Approved for Non-Cystic Fibrosis Bronchiectasis in the European Union
2025-11-13 07:00U:INSMNews ReleaseInsmed Strengthens Communities Worldwide During Fourth Annual Global Day of Good
2025-11-05 07:00U:INSMNews ReleaseInsmed To Present at November and December 2025 Investor Conferences
2025-10-30 07:00U:INSMNews ReleaseInsmed Reports Third-Quarter 2025 Financial Results and Provides Business Update
2025-10-23 16:05U:INSMNews ReleaseInsmed Ranks No. 1 on Science's 2025 Top Biopharma Employers List
2025-10-17 07:00U:INSMNews ReleaseCHMP Recommends EU Approval of BRINSUPRI(TM) (brensocatib) for the Treatment of Non-Cystic Fibrosis Bronchiectasis
2025-10-16 07:00U:INSMNews ReleaseInsmed to Present Multiple Analyses from Phase 3 ASPEN Study at the American College of Chest Physicians Annual Meeting 2025
2025-10-15 07:00U:INSMNews ReleaseInsmed to Host Third-Quarter 2025 Financial Results Conference Call on Thursday, October 30, 2025
2025-09-22 07:00U:INSMNews ReleaseInsmed to Present Multiple Abstracts at the European Respiratory Society Congress 2025
2025-09-05 07:00U:INSMNews ReleaseInsmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
2025-08-21 07:00U:INSMNews ReleaseInsmed To Present at September Investor Conferences
2025-08-12 11:34U:INSMNews ReleaseFDA Approves BRINSUPRI(TM) (brensocatib) as the First and Only Treatment for Non-Cystic Fibrosis Bronchiectasis, a Serious, Chronic Lung Disease
2025-08-07 07:00U:INSMNews ReleaseInsmed Reports Second-Quarter 2025 Financial Results and Provides Business Update
2025-07-24 07:00U:INSMNews ReleaseInsmed to Host Second-Quarter 2025 Financial Results Conference Call on Thursday, August 7, 2025